These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9676793)

  • 1. Percutaneous intervention: design, technique, and pharmacology.
    Linnemeier TJ
    Cathet Cardiovasc Diagn; 1998 Jul; 44(3):265-6. PubMed ID: 9676793
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary artery stents.
    Stewart AJ; Coltart DJ
    Postgrad Med J; 1996 May; 72(847):274-6. PubMed ID: 8761499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation therapy: a stage in the history of percutaneous coronary intervention].
    Lablanche JM
    Arch Mal Coeur Vaiss; 2006 Feb; 99 Spec no.3():3-4. PubMed ID: 16553236
    [No Abstract]   [Full Text] [Related]  

  • 5. Is anticoagulation for intracoronary stenting justified?
    Corr L
    Eur Heart J; 1996 Sep; 17(9):1296-8. PubMed ID: 8880009
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?
    Silvain J; Montalescot G
    Arch Cardiovasc Dis; 2012 May; 105(5):259-61. PubMed ID: 22709466
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin for coronary angioplasty: high dose, low dose, or no dose?
    Garachemani A; Meier B
    Heart; 1998 Jul; 80(1):3-4. PubMed ID: 9764047
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-molecular-weight heparins in percutaneous coronary interventions.
    Kar AK; Dutta I
    Indian Heart J; 2003; 55(1):81-7. PubMed ID: 12760596
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant therapy for percutaneous coronary intervention.
    Rao SV; Ohman EM
    Circ Cardiovasc Interv; 2010 Feb; 3(1):80-8. PubMed ID: 20160186
    [No Abstract]   [Full Text] [Related]  

  • 10. How should I treat a "swinging" left main thrombosis complicating coronary angioplasty in an obese, diabetic, elderly woman treated with fondaparinux?
    Brunetti ND; Centola A; Campanale EG; Cuculo A; Ruggiero A; Ziccardi L; De Gennaro L; Di Biase M
    EuroIntervention; 2012 Apr; 7(12):1470-5. PubMed ID: 22522557
    [No Abstract]   [Full Text] [Related]  

  • 11. Very late drug-eluting stent thrombosis.
    Clark DJ; Wong MC; Chan RK; Oliver LE; Ajani AE
    Cardiovasc Revasc Med; 2007; 8(1):72-5. PubMed ID: 17293273
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-eluting coronary stents: what are the risks?
    Kersten JR; Fleisher LA
    Anesthesiology; 2007 May; 106(5):898-900. PubMed ID: 17457119
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 14. Current incidence and clinical outcomes of bivalirudin administration among patients undergoing primary coronary intervention for stent thrombosis elevation acute myocardial infarction.
    Dauerman HL; Frederick PD; Miller D; French WJ;
    Coron Artery Dis; 2007 Mar; 18(2):141-8. PubMed ID: 17301606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy: an unrecognized risk factor for coronary stent thrombosis?
    Hobson AR; McKenzie DB; Kunadian V; Purcell I; Zaman A; Dawkins KD; Curzen N
    J Invasive Cardiol; 2008 Apr; 20(4):E120-3. PubMed ID: 18398242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting.
    Wilson SH; Fasseas P; Orford JL; Lennon RJ; Horlocker T; Charnoff NE; Melby S; Berger PB
    J Am Coll Cardiol; 2003 Jul; 42(2):234-40. PubMed ID: 12875757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis.
    Colombo A
    Am J Cardiol; 2003 Oct; 92(8):1013; author reply 1013-4. PubMed ID: 14556889
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of 'resistant' thrombus: all you can hit in very late stent thrombosis.
    Vergallo R; D'Amario D; Annibali G; Galli M; Crea F; Porto I
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):397-399. PubMed ID: 30865136
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
    Zubaid M; Penn IM; Buller CE; Moscovich MD; Ricci DR; Chauhan A
    Can J Cardiol; 1997 Apr; 13(4):335-40. PubMed ID: 9141964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.